Keith Regnante

Affiliations

  • Chief Financial Officer at Keros Therapeutics Inc. (KROS), 2021-01-12
  • Chief Financial Officer at Wave Life Sciences Ltd. (WVE), 2019-03-11
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
WVE $36.84 1,298 Officer 15,686 2019-02-19 Filing
WVE $55.00 29,500 Officer 16,984 2018-09-24 Filing
WVE $51.85 316 Officer 16,984 2018-02-16 Filing